Vivimed Labs launches Covid-19 drug Favulous in India
Vivimed Labs has launched Favulous, its generic version of Covid-19 drug Favipiravir Tablet 200 mg and 400 mg in India. The launch follows the approval secured by the Hyderabad-based specialty chemicals and pharma company secured approval from the Indian Director General of Health Services (DGHS) for manufacturing and marketing Favipiravir. Vivimed Labs said that it […]